|
US7192584B2
(en)
*
|
1991-03-18 |
2007-03-20 |
Centocor, Inc. |
Methods of treating psoriasis with anti-TNF antibodies
|
|
US6355450B1
(en)
|
1995-04-21 |
2002-03-12 |
Human Genome Sciences, Inc. |
Computer readable genomic sequence of Haemophilus influenzae Rd, fragments thereof, and uses thereof
|
|
US20050131222A1
(en)
|
1995-04-21 |
2005-06-16 |
Human Genome Sciences, Inc. |
Nucleotide sequence of the haemophilus influenzae Rd genome, fragments thereof, and uses thereof
|
|
US6551795B1
(en)
|
1998-02-18 |
2003-04-22 |
Genome Therapeutics Corporation |
Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
|
|
US6696550B2
(en)
|
1998-07-23 |
2004-02-24 |
Millennium Pharmaceuticals, Inc. |
Humanized anti-CCR2 antibodies and methods of use therefor
|
|
US6303321B1
(en)
|
1999-02-11 |
2001-10-16 |
North Shore-Long Island Jewish Research Institute |
Methods for diagnosing sepsis
|
|
US20020042386A1
(en)
|
2000-01-31 |
2002-04-11 |
Rosen Craig A. |
Nucleic acids, proteins, and antibodies
|
|
WO2001070266A2
(en)
|
2000-03-17 |
2001-09-27 |
Millennium Pharmaceuticals, Inc. |
Method of inhibiting stenosis and restenosis with a mixture of antibodies anti cd18 and anti ccr2
|
|
KR100390332B1
(ko)
|
2000-08-02 |
2003-07-07 |
유원민 |
항말라리아제와 항암제의 병용투여에 의한 항암제 복합 조성물
|
|
AU2002307448A1
(en)
|
2001-04-20 |
2002-11-05 |
President And Fellows Of Harvard College |
Methods and compositions for the modulation of biofilm formation
|
|
WO2004001058A2
(en)
|
2001-05-04 |
2003-12-31 |
Paratek Pharmaceuticals, Inc. |
Transcription factor modulating compounds and methods of use thereof
|
|
EP1392844A4
(en)
|
2001-05-15 |
2006-09-06 |
Long Island Jewish Res Inst |
USE OF HMG FRAGMENTS AS ANTI-INFLAMMATORY AGENTS
|
|
JP4511173B2
(ja)
|
2001-08-24 |
2010-07-28 |
マイジェニックス インコーポレイテッド |
抗菌性および抗炎症性ペプチド
|
|
ITMI20011986A1
(it)
|
2001-09-25 |
2003-03-25 |
San Raffaele Centro Fond |
Metodo e composizione per l'attivazione di cellule presentanti l'antigene
|
|
US20030099602A1
(en)
|
2001-10-25 |
2003-05-29 |
Levin Gilbert V. |
D-tagatose as an anti-biofilm agent
|
|
EP1524991A1
(en)
|
2002-08-02 |
2005-04-27 |
GlaxoSmithKline Biologicals S.A. |
Vaccine composition comprising transferrin binding protein and hsf from gram negative bacteria
|
|
GB0226251D0
(en)
|
2002-11-11 |
2002-12-18 |
San Raffaele Centro Fond |
Acetylated protein
|
|
CA2506328A1
(en)
*
|
2002-11-20 |
2004-06-03 |
Critical Therapeutics, Inc. |
Use of hmgb fragments as anti-inflammatory agents
|
|
JP2006506441A
(ja)
|
2002-11-20 |
2006-02-23 |
ノース ショア−ロング アイランド ジュ−イッシュ リサ−チ インスティチュ−ト |
免疫応答を増大させるためのｈｍｇｂポリペプチドの使用
|
|
DE60333228D1
(de)
|
2002-12-02 |
2010-08-12 |
Amgen Fremont Inc |
Gegen den tumor nekrose faktor gerichtete antikörper und deren verwendungen
|
|
EP1579221A2
(de)
|
2003-01-03 |
2005-09-28 |
Alcedo Biotech GmbH |
Verwendungen von hmgb, hmgn, hmga proteinen
|
|
US7297340B2
(en)
|
2003-01-07 |
2007-11-20 |
University Of Iowa Research Foundation |
Vaccine and method for preventing biofilm formation
|
|
EP1592707A2
(en)
|
2003-02-14 |
2005-11-09 |
Fondazione Centro San Raffaele Del Monte Tabor |
Hmgb1 modulator binding domain
|
|
WO2006138527A2
(en)
|
2005-06-16 |
2006-12-28 |
Children's Hospital, Inc. |
Genes of an otitis media isolate of nontypeable haemophilus influenzae
|
|
CA2796381A1
(en)
|
2003-03-06 |
2004-09-16 |
Children's Hospital, Inc. |
Genes of an otitis media isolate of nontypeable haemophilus influenzae
|
|
WO2005025604A2
(en)
|
2003-09-10 |
2005-03-24 |
The General Hospital Corporation |
Use of hmgb and hmgb fragments to decrease specific immune response
|
|
US7413868B2
(en)
|
2003-11-05 |
2008-08-19 |
Trellis Bioscience, Inc. |
Use of particulate labels in bioanalyte detection methods
|
|
AU2005226420A1
(en)
|
2004-03-26 |
2005-10-06 |
Locomogene, Inc. |
Decoy nucleic acid to synoviolin gene promoter
|
|
US8728525B2
(en)
|
2004-05-12 |
2014-05-20 |
Baxter International Inc. |
Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
|
|
GB0410866D0
(en)
|
2004-05-14 |
2004-06-16 |
Chiron Srl |
Haemophilius influenzae
|
|
WO2006083301A2
(en)
|
2004-06-17 |
2006-08-10 |
Medimmune, Inc. |
Immunogenic compositions comprising hmgb1 polypeptides
|
|
EP1799255A4
(en)
|
2004-06-25 |
2008-10-01 |
Medimmune Vaccines Inc |
RECOMBINANT HUMANESE CYTOMEGALOVIRUS AND HETEROLOGIST ANTIGENS CONTAINING VACCINES
|
|
US20060030539A1
(en)
|
2004-08-06 |
2006-02-09 |
National Jewish Medical And Research Center |
Product and process for inhibition of biofilm development
|
|
US7585504B2
(en)
|
2004-10-22 |
2009-09-08 |
Medimmune, Llc |
High affinity antibodies against HMGB1 and methods of use thereof
|
|
AU2006214064B2
(en)
|
2005-02-18 |
2012-04-26 |
J. Craig Venter Institute, Inc. |
Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
|
|
US20060228384A1
(en)
|
2005-04-06 |
2006-10-12 |
Sequoia Sciences, Inc. |
Control of biofilm with a biofilm inhibitor
|
|
WO2006114805A2
(en)
|
2005-04-28 |
2006-11-02 |
Fondazione Centro San Raffaele Del Monte Tabor |
Use of hmgb2 and hmgb3 proteins for medical applications
|
|
DE602006018308D1
(de)
|
2005-07-08 |
2010-12-30 |
Nationwide Childrens Hospital |
Chimärer impfstoff für haemophilus influenzae-induzierte infektion
|
|
WO2007044406A2
(en)
|
2005-10-04 |
2007-04-19 |
Ludwig Institute For Cancer Research |
Methods for stimulating an immune response using bacterial antigen delivery system
|
|
CA2642754A1
(en)
|
2006-02-13 |
2007-08-23 |
Trustees Of Boston University |
Compositions and methods for antibiotic potentiation and drug discovery
|
|
US20070286822A1
(en)
|
2006-06-12 |
2007-12-13 |
Anacor Pharmaceuticals Inc. |
Compounds for the Treatment of Periodontal Disease
|
|
PL2061886T3
(pl)
|
2006-08-21 |
2014-10-31 |
Univ British Columbia |
Małe kationowe peptydy immunomodulujące
|
|
AU2007296843C1
(en)
*
|
2006-09-15 |
2012-08-16 |
Creabilis Therapeutics S.P.A. |
Polymer conjugates of Box-A of HMGB1 and Box-A variants of HMGB1
|
|
EP1980269A1
(en)
|
2007-04-13 |
2008-10-15 |
Katholieke Universiteit Leuven |
Prevention of staphylococcus biofilm formation
|
|
NZ595252A
(en)
|
2007-07-12 |
2013-11-29 |
Oral Health Australia Pty Ltd |
Biofilm treatment
|
|
MX2012010793A
(es)
*
|
2010-03-29 |
2013-05-09 |
Univ Southern California |
Composiciones y metodos para la eliminacion de biopeliculas.
|
|
EP2613797B1
(en)
|
2010-09-09 |
2015-11-04 |
University Of Southern California |
Compositions and methods for the removal of biofilms
|
|
US9746475B2
(en)
|
2011-03-14 |
2017-08-29 |
University Of Southern California |
Antibody and antibody mimetic for visualization and ablation of endogenous proteins
|
|
WO2012151555A1
(en)
|
2011-05-04 |
2012-11-08 |
President And Fellows Of Harvard College |
Methods and coatings for treating biofilms
|
|
US20130183323A1
(en)
|
2011-12-19 |
2013-07-18 |
Hua Wang |
Targeted antibiotic and antimicrobial treatments for personalized administration
|
|
US10722577B2
(en)
|
2012-05-25 |
2020-07-28 |
Sloan Kettering Institute For Cancer Research |
Methods for treating GI syndrome and graft versus host disease
|
|
AU2013271336B2
(en)
|
2012-06-04 |
2017-11-30 |
Centre For Digestive Diseases |
Compositions and methods for treating Crohn's Disease and related conditions and infections
|
|
WO2014016417A1
(en)
*
|
2012-07-26 |
2014-01-30 |
Ospedale San Raffaele Srl |
Hmgb1 variants and uses thereof
|
|
WO2014070769A1
(en)
|
2012-10-29 |
2014-05-08 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for treating mucosal tissue disorders
|
|
EP2941128B1
(en)
|
2012-12-20 |
2023-06-28 |
Rajiv Bhushan |
Antimicrobial compositions
|
|
CA2913162C
(en)
|
2013-05-22 |
2021-07-27 |
Curza Global, Llc |
Compositions and methods comprising a polyamine
|
|
US11274144B2
(en)
|
2013-06-13 |
2022-03-15 |
Research Institute At Nationwide Children's Hospital |
Compositions and methods for the removal of biofilms
|
|
CA2915210A1
(en)
|
2013-06-13 |
2014-12-18 |
Research Institute At Nationwide Children's Hospital |
Compositions and methods for the treatment of burkholderia infections
|
|
US20160194384A1
(en)
|
2014-06-12 |
2016-07-07 |
Research Institute At Nationwide Children's Hospital |
Compositions and methods for the removal of biofilms
|
|
US20160289287A1
(en)
|
2013-08-27 |
2016-10-06 |
The University Of British Columbia |
Small cationic anti-biofilm and idr peptides
|
|
US11013858B2
(en)
|
2016-01-12 |
2021-05-25 |
David S. Goldsmith |
Nonjacketing side-entry connectors and prosthetic disorder response systems
|
|
US9745366B2
(en)
|
2013-09-23 |
2017-08-29 |
University Of Southern California |
Compositions and methods for the prevention of microbial infections
|
|
US20150086561A1
(en)
|
2013-09-26 |
2015-03-26 |
Trellis Bioscience, Llc |
Binding moieties for biofilm remediation
|
|
US10233234B2
(en)
|
2014-01-13 |
2019-03-19 |
Trellis Bioscience, Llc |
Binding moieties for biofilm remediation
|
|
US20150299298A1
(en)
|
2013-09-26 |
2015-10-22 |
Trellis Bioscience, Llc |
Binding moieties for biofilm remediation
|
|
US20150197558A1
(en)
|
2013-09-26 |
2015-07-16 |
Trellis Bioscience, Llc |
Binding moieties for biofilm remediation
|
|
US11248040B2
(en)
|
2013-09-26 |
2022-02-15 |
Trellis Bioscience, Llc |
Binding moieties for biofilm remediation
|
|
US10624934B2
(en)
|
2014-03-06 |
2020-04-21 |
Research Institute At Nationwide Children's Hospital |
Prebiotic formulations
|
|
CA2941933A1
(en)
|
2014-03-13 |
2015-09-17 |
The Secretary Of State For Health |
Antimicrobial conjugates, method for production and uses thereof
|
|
WO2016154491A1
(en)
|
2015-03-25 |
2016-09-29 |
Trellis Bioscience, Llc |
Binding moieties for biofilm remediation
|
|
US9801909B2
(en)
|
2015-04-06 |
2017-10-31 |
The Penn State Research Foundation |
Compositions and methods for combating bacterial infections by killing persister cells with mitomycin C
|
|
GB201508337D0
(en)
|
2015-05-15 |
2015-06-24 |
Hmgbiotech S R L |
Novel peptides
|
|
US20160340650A1
(en)
|
2015-05-21 |
2016-11-24 |
Batu Biologics, Inc. |
Blood derived immune stimulatory compositions
|
|
AU2016303688B2
(en)
|
2015-07-31 |
2023-06-15 |
Research Institute At Nationwide Children's Hospital |
Peptides and antibodies for the removal of biofilms
|
|
WO2017066719A2
(en)
|
2015-10-14 |
2017-04-20 |
Research Institute At Nationwide Children's Hospital |
Hu specific interfering agents
|
|
AU2016365423A1
(en)
|
2015-12-04 |
2018-07-12 |
The Regents Of The University Of California |
Novel antibodies for the treatment of cancers
|
|
US20170182205A1
(en)
|
2015-12-28 |
2017-06-29 |
ProclaRx LLC |
Medical devices with biofilm disruptors
|
|
WO2017192594A1
(en)
|
2016-05-02 |
2017-11-09 |
Trellis Bioscience, Llc |
Binding moieties for biofilm remediation
|
|
JP2019530440A
(ja)
|
2016-09-02 |
2019-10-24 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
インターロイキン６受容体α結合単鎖可変断片を含む方法および組成物
|
|
FR3055801B1
(fr)
|
2016-09-15 |
2020-10-30 |
Virbac |
Derives esters de squalamine pour le traitement des infections
|
|
AU2018206560B9
(en)
|
2017-01-04 |
2025-04-03 |
Research Institute At Nationwide Children's Hospital |
Antibody fragments for the treatment of biofilm-related disorders
|
|
JP7514621B2
(ja)
|
2017-01-04 |
2024-07-11 |
リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル |
Ｄｎａｂｉｉワクチンおよび強化された活性を有する抗体
|
|
AU2018236271B2
(en)
|
2017-03-15 |
2023-12-21 |
Research Institute At Nationwide Children's Hospital |
Composition and methods for disruption of bacterial biofilms without accompanying inflammation
|
|
CA3058813A1
(en)
|
2017-04-05 |
2018-10-11 |
University Of Utah Research Foundation |
Compositions and methods comprising a triaryl polyamine
|
|
US20210139610A1
(en)
|
2018-06-29 |
2021-05-13 |
Research Institute At Nationwide Children's Hospital |
Compositions and methods for mediating eps
|
|
WO2020038963A1
(en)
|
2018-08-21 |
2020-02-27 |
Modiquest B.V. |
Antibodies binding to citrullinated histone 2a and/or 4
|
|
SG11202103001PA
(en)
|
2018-10-05 |
2021-04-29 |
Res Inst Nationwide Childrens Hospital |
Hmgb1 protein derivatives for the removal of biofilms cross-reference to related application
|
|
EA202191176A1
(ru)
|
2018-10-31 |
2021-07-28 |
Делиниа, Инк. |
Поливалентные модуляторы регуляторных т-клеток
|
|
WO2021007260A2
(en)
|
2019-07-08 |
2021-01-14 |
Research Institute At Nationwide Children's Hospital |
Antibody compositions for disrupting biofilms
|